Diminishing angiogenesis and tumor growth by depleting TAMs with approaches including CSF1 inactivation, CSF1 receptor (CSF1R) antibodies, and clodronate liposomes has been shown in a variety of tumor types (100, 101). Here, CSF1R is linked to neoplasm.